1. Clinical pharmacokinetics of systemic antifungal drugs. Clin Pharmacokin 1983; 8: 17-42. A review of amphotericin B, flucytosine, miconazole, and ketoconazole;Daneshmend, T.K.; Warnock, D.W.
2. Ketonconazole versus nystatin and amphotericin B for fungal prophylaxis in severely immunocompromised patients;Hann, I.M.; Prentice, H.G.; Coringham, R.;Lancet,1982
3. The imidazoles;Holt, R.J.,1980
4. Jones HE. Ketoconazole. Arch Dermatol 1982;118:217-9.
5. and therapeutic role are reviewed in relation to dermatological uses. Warnock DW, Speller DCE;Pharmacology, adverse effects;Antifungals today. 7 Antimicrob Chemother,1982